METACRINE INC
METACRINE INC
Acción · US59101E1038 · MTCR (XNAS)
Resumen Indicadores financieros
Sin cotización
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - 0,00 % 0,00 % -95,06 %

Company Profile for METACRINE INC Share

Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Company Data

Name METACRINE INC
Company Metacrine, Inc.
Symbol MTCR
Website https://www.metacrine.com
Primary Exchange XNAS NASDAQ
ISIN US59101E1038
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. David M. Maggio
Country United States of America
Currency USD
Employees 0,0 T
Address 3985 Sorrento Valley Boulevard, 92121 San Diego
IPO Date 2020-09-16
Dividenden von 'METACRINE INC'
Ex-Datum Dividende pro Aktie
21.06.2023 0,58 USD

Ticker Symbole

Name Symbol
NASDAQ MTCR

Weitere Aktien

Investoren die METACRINE INC die halten, haben auch folgende Aktien im Depot:
LONZA GROUP AG
LONZA GROUP AG Aktie
UNIPOL GRUPPO SPA NAM.
UNIPOL GRUPPO SPA NAM. Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025